PATENT CLAIM ANALYSIS

Application Number: 15897776
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["546", "238000"]

Abstract:
A method of treating HIV in a subject, comprising administering to a subject in need thereof a therapeutically effective amount of a compound having a general Formula 1, or a pharmaceutically acceptable salt or ester thereof: wherein R 1  is selected from H, optionally-substituted aryl, optionally-substituted heteroaryl, or optionally-substituted aliphatic; each R 2  is independently selected from H, halogen, cyano, thioether, oxo, optionally-substituted amino, optionally-substituted heteroaryl, optionally-substituted aryl, or optionally-substituted aliphatic; a is 3 to 7; and the ring designates a heterocyclic or heteroaryl structure.

Claim (Index 4):
A method of treating a Nef-mediated disease in a subject, comprising administering to a subject in need thereof a therapeutically effective amount of a compound having a general Formula 1b, or a pharmaceutically acceptable salt or ester thereof: wherein R 8  is H, optionally-substituted aryl, optionally-substituted heteroaryl or optionally-substituted aliphatic; and R 10  and R 11  together form a heteroaryl ring.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 88.0
- Lexical Diversity: 1.83929
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15042069', '14441475', '15309728', '15589590', '14836774']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7870875944788097
- 35 USC 102 Novelty (BERT): 0.5545057796413947
- Combined Prediction Score: 0.7638294129950682
- Mean Citation Score: 328.994648
- Max Citation Score: 458.2768
- Similarity Product: 326.7568212666511

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test